Patents by Inventor Lela BUCKINGHAM

Lela BUCKINGHAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and methods for predicting recurrence of non-small cell lung cancer
    Patent number: 8969001
    Abstract: Disclosed herein is a DNA methylation-based test for determining the recurrence or non-recurrence of a lung cancer such as NSCLC after treatment. The assays involve the detection of methylation of the BAX gene promoter alone or in combination with other genes. The test is suitable for monitoring treatment of subjects with lung cancer for which methylation differs by stage of the disease and by treatment regimen.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: March 3, 2015
    Assignee: Rush University Medical Center
    Inventor: Lela Buckingham
  • MATERIALS AND METHODS FOR PREDICTING RECURRENCE OF NON-SMALL CELL LUNG CANCER
    Publication number: 20100233707
    Abstract: Disclosed herein is a DNA methylation-based test for determining the recurrence or non-recurrence of a lung cancer such as NSCLC after treatment. The assays involve the detection of methylation of the BAX gene promoter alone or in combination with other genes. The test is suitable for monitoring treatment of subjects with lung cancer for which methylation differs by stage of the disease and by treatment regimen.
    Type: Application
    Filed: March 11, 2010
    Publication date: September 16, 2010
    Inventor: Lela BUCKINGHAM